Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus-Reference-Cited by-同舟云学术

Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

Published:2019-06-20 Issue:8 Volume:85 Page:1820-1828
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Busse David¹,Tang Weifeng²,Scheerer Markus³,Danne Thomas⁴,Biester Torben⁴^ORCID,Sokolov Viktor⁵,Boulton David²,Parkinson Joanna¹^ORCID

Affiliation:

1. Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech UnitAstraZeneca Gothenburg Sweden

2. Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech UnitAstraZeneca Gaithersburg MD USA

3. Diabetes Medical DepartmentAstraZeneca GmbH Wedel Germany

4. AUF DER BULTChildren's and Youth Hospital Hannover Germany

5. M&S Decisions Moscow Russia

Funder

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13981

Reference25 articles.

1. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

2. Treatment of diabetes in children

3. Mortality in type 1 diabetes in the DCCT/EDIC vs the general population;DCCT/EDIC;Diabetes Care,2016

4. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report;Journal of International Medical Research;2024-08

2. Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review;Pediatric Drugs;2024-04-18

3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease;Kidney International;2024-04

4. Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus;British Journal of Clinical Pharmacology;2023-11-20

5. Pharmacogenetics of sodium‐glucose co‐transporter‐2 inhibitors: Validation of a sex‐agnostic pharmacodynamic biomarker;Diabetes, Obesity and Metabolism;2023-08-22